Background
Background There have been few
There have been few detailed longitudinal symptom studies of detailed longitudinal symptom studies of bipolar disorder. bipolar disorder.
Aims Aims To describe the course of bipolar
To describe the course of bipolar disorder over18 months in 204 patients disorder over18 months in 204 patients receiving mental healthcare. receiving mental healthcare.
Method Method Patients were interviewed
Patients were interviewed every 8 weeks, with weekly ratings of every 8 weeks, with weekly ratings of depression, mania and overall severity. depression, mania and overall severity.
Results

Results Participants were symptomatic
Participants were symptomatic 53% of the time, with sub-syndromal 53% of the time, with sub-syndromal symptoms present for twice as long as symptoms present for twice as long as major disorder, and depressive symptoms major disorder, and depressive symptoms three times more than manic symptoms. three times more than manic symptoms. Individuals who were experiencing an Individuals who were experiencing an episode at baseline spent 33% of the18 episode at baseline spent 33% of the18 months with substantial sub-syndromal months with substantial sub-syndromal symptoms,17% with major disorder and symptoms,17% with major disorder and 28% symptom free.Those not 28% symptom free.Those not experiencing a baseline episode spent experiencing a baseline episode spent twice aslong symptom free and half aslong twice aslong symptomfree and half aslong at disorder levels.Changes in symptom at disorder levels.Changes in symptom level were frequent.Predictors of sublevel were frequent.Predictors of subsyndromal symptoms were similar to syndromal symptoms were similar to those of major disorder. those of major disorder.
Conclusions Conclusions Sub-syndromal residual
Sub-syndromal residual symptoms are an important problem in symptoms are an important problem in recurrent bipolar disorder and require recurrent bipolar disorder and require therapeutic intervention. therapeutic intervention.
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The course of unipolar affective disorder is The course of unipolar affective disorder is now recognised to show not only clear-cut now recognised to show not only clear-cut episodes of major disorder, but also considepisodes of major disorder, but also considerable periods of inter-episode lower-level erable periods of inter-episode lower-level symptoms (Paykel symptoms (Paykel et al et al, 1995; Judd , 1995; Judd et al et al, , 1998) , with continuity between major and 1998), with continuity between major and minor symptoms and subtypes. In bipolar minor symptoms and subtypes. In bipolar disorder, whereas milder forms such as disorder, whereas milder forms such as bipolar II disorder and cyclothymic disbipolar II disorder and cyclothymic disorder are well recognised, there has been order are well recognised, there has been less study of subthreshold symptoms less study of subthreshold symptoms between major episodes. Two of us between major episodes. Two of us (Kennedy (Kennedy et al et al, 2003) recently reported a , 2003) recently reported a 10-year longitudinal follow-up study of 10-year longitudinal follow-up study of symptom levels in unipolar depression. symptom levels in unipolar depression. The present paper reports the first UK The present paper reports the first UK longitudinal study of bipolar disorder, longitudinal study of bipolar disorder, using similar methods. using similar methods.
METHOD METHOD Sample Sample
The sample was from a randomised The sample was from a randomised controlled trial of cognitive therapy precontrolled trial of cognitive therapy previously reported in detail (Scott viously reported in detail (Scott et al et al, , 2006) . At five sites (Cambridge, Glasgow, 2006) . At five sites (Cambridge, Glasgow, Liverpool, Manchester and Preston), Liverpool, Manchester and Preston), including both inner-city and more-rural including both inner-city and more-rural areas, all eligible patients with bipolar areas, all eligible patients with bipolar disorder were recruited from general adult disorder were recruited from general adult psychiatry services that served defined psychiatry services that served defined geographical catchment areas. Participants geographical catchment areas. Participants were given oral and written information were given oral and written information and gave written informed consent. Ethical and gave written informed consent. Ethical approval was given by the North-East approval was given by the (c) (c) currently meeting DSM-IV criteria for currently meeting DSM-IV criteria for mania (these patients were included mania (these patients were included after symptoms improved and patients after symptoms improved and patients with current hypomania or a mixed with current hypomania or a mixed affective episode were included); affective episode were included);
(d) (d) rapid-cycling bipolar disorder (more rapid-cycling bipolar disorder (more than four episodes alternating in the than four episodes alternating in the past year with less than a month past year with less than a month between); between); (e) (e) severe borderline personality disorder severe borderline personality disorder with suicidal ideation or intent in the with suicidal ideation or intent in the past 3 months; past 3 months;
(f) (f) current systematic psychological treatcurrent systematic psychological treatment for bipolar disorder; ment for bipolar disorder;
(g) (g) inability to read and write English. inability to read and write English.
Treatment and follow-up Treatment and follow-up
Participants were randomised by minimisaParticipants were randomised by minimisation, to receive in equal proportions either tion, to receive in equal proportions either treatment as usual from their usual treatment as usual from their usual catchment-area mental health teams, or catchment-area mental health teams, or treatment as usual plus cognitive therapy treatment as usual plus cognitive therapy from trained therapists in up to 20 sessions from trained therapists in up to 20 sessions over 26 weeks. All patients were followed over 26 weeks. All patients were followed up if possible for a further 12 months to a up if possible for a further 12 months to a total of 18 months (72 weeks), irrespective total of 18 months (72 weeks), irrespective of recurrence or drop-out from the conof recurrence or drop-out from the controlled trial. trolled trial.
Outcome measures Outcome measures
Research assistants masked to treatment Research assistants masked to treatment condition conducted baseline assessment condition conducted baseline assessment interviews before randomisation and then interviews before randomisation and then every 8 weeks for 72 weeks. Training was every 8 weeks for 72 weeks. Training was undertaken for a preliminary 3 months, undertaken for a preliminary 3 months, including joint monthly meetings with including joint monthly meetings with audiotaped practice interviews reviewed audiotaped practice interviews reviewed and re-rated, and differences were discussed and re-rated, and differences were discussed and resolved. Reliability was subsequently and resolved. Longitudinal severity ratings of sympLongitudinal severity ratings of symptom levels were made at baseline for the tom levels were made at baseline for the current week and at follow-up interviews current week and at follow-up interviews for each week since the last assessment (8 for each week since the last assessment (8 weeks), based on the LIFE-II Longitudinal weeks), based on the LIFE-II Longitudinal Interval Follow-up Evaluation (LIFE-II; Interval Follow-up Evaluation (LIFE-II; Keller Keller et al et al, 1987; Keller , 1987; Keller et al et al, 1992) . , 1992). Two LIFE scores were rated, one for mania Two LIFE scores were rated, one for mania and one for depression, and each used a sixand one for depression, and each used a sixpoint scale where 1 point scale where 1¼no symptoms. The no symptoms. The criteria used for these ratings are shown in criteria used for these ratings are shown in Table 1 . Rating scores could be assigned Table 1 . Rating scores could be assigned simultaneously for mania and depression simultaneously for mania and depression if mixed symptoms were present. For if mixed symptoms were present. For analysis, a further rating of overall severity analysis, a further rating of overall severity with the most-severe rating for either mania with the most-severe rating for either mania or depression was used, irrespective of or depression was used, irrespective of which. For analysis these were grouped into which. For analysis these were grouped into four levels: 1 four levels: 1¼no symptoms; 2 no symptoms; 2¼minor minor symptoms; 3,4 symptoms; 3,4¼sub-syndromal symptoms; sub-syndromal symptoms; 5,6 5,6¼major disorder. Interrater reliability major disorder. Interrater reliability on the LIFE and other measures was on the LIFE and other measures was assessed by the method of Bland & Altman assessed by the method of Bland & Altman (1986) as used for repeatability, on 110 (1986) as used for repeatability, on 110 joint ratings from tapes. For the depression joint ratings from tapes. For the depression rating only 3.6% (4 out of 110), and for the rating only 3.6% (4 out of 110), and for the mania rating 2.7% (3 out of 110), of rating mania rating 2.7% (3 out of 110), of rating pair differences from their joint means were pair differences from their joint means were 
Data analyses Data analyses
Overall trial outcome showed no significant Overall trial outcome showed no significant differences between the treatment groups differences between the treatment groups on recurrence, LIFE scores or other key on recurrence, LIFE scores or other key rating variables (Scott rating variables (Scott et al et al, 2006) . The , 2006) . The analyses in this paper combine the two analyses in this paper combine the two treatment groups, and are based on LIFE treatment groups, and are based on LIFE ratings, using the three scores respectively ratings, using the three scores respectively for depression, mania and overall severity, for depression, mania and overall severity, each grouped according to the four levels each grouped according to the four levels described in the previous section. To avoid described in the previous section. To avoid overemphasis of small fluctuations, LIFE overemphasis of small fluctuations, LIFE scores were averaged over the four weekly scores were averaged over the four weekly ratings to provide a monthly rating, and ratings to provide a monthly rating, and means were rounded to the nearest integer means were rounded to the nearest integer (0.5 rounded up), for grouped analyses. (0.5 rounded up), for grouped analyses. Data were analysed using the Statistical Data were analysed using the Statistical Package for the Social Sciences for WinPackage for the Social Sciences for Windows, version 11.0. Group differences were dows, version 11.0. Group differences were tested for significance by two-tailed tested for significance by two-tailed t t-tests, -tests, with the 5% level accepted. Predictor anawith the 5% level accepted. Predictor analyses were by univariate logistic regressions. lyses were by univariate logistic regressions.
RESULTS RESULTS
Sample characteristics Sample characteristics
In total, 253 patients were included in the In total, 253 patients were included in the main controlled trial, derived from 1260 main controlled trial, derived from 1260 patients available for initial screening; the patients available for initial screening; the major cause of loss was failure to meet major cause of loss was failure to meet inclusion criteria, and also some noninclusion criteria, and also some nonconsent for the controlled trial (Scott consent for the controlled trial (Scott et al et al, , 2006) . For the analyses reported here, to 2006). For the analyses reported here, to avoid bias in later ratings owing to selective avoid bias in later ratings owing to selective loss of participants with early drop-out and loss of participants with early drop-out and subsequent missing ratings, the sample was subsequent missing ratings, the sample was reduced by eliminating 49 individuals who reduced by eliminating 49 individuals who lacked all subsequent ratings at any point lacked all subsequent ratings at any point before 40 weeks (including 17 missing all before 40 weeks (including 17 missing all ratings after baseline, and 8 lacking all ratratings after baseline, and 8 lacking all ratings after 8 weeks). Other missing ratings ings after 8 weeks). Other missing ratings were not imputed, but percentages and were not imputed, but percentages and means were based on available ratings. means were based on available ratings.
The remaining 204 patients were of The remaining 204 patients were of mean age 42.0 years (s.d. mean age 42.0 years (s.d.¼11.0); 133 11.0); 133 (65%) were women; 101 (50%) were of (65%) were women; 101 (50%) were of social class Registrar General classification social class Registrar General classification Classes I-III (non-manual); 133 (65%) Classes I-III (non-manual); 133 (65%) were not in bipolar episode at inclusion; were not in bipolar episode at inclusion; 52 (26%) were in a major depressive 52 (26%) were in a major depressive episode; and 19 (9%) were in a hypomanic episode; and 19 (9%) were in a hypomanic or mixed episode. DSM-IV diagnoses of or mixed episode. DSM-IV diagnoses of most recent episodes were depressive 107 most recent episodes were depressive 107 (52%), manic 66 (32%) and hypomanic (52%), manic 66 (32%) and hypomanic 31 (15%). Participants had had a median 31 (15%). Participants had had a median of 11 previous bipolar episodes (depression of 11 previous bipolar episodes (depression median 5, mania median 4); 67 (33%) had median 5, mania median 4); 67 (33%) had received a lifetime diagnosis of a comorbid received a lifetime diagnosis of a comorbid non-bipolar disorder; 89 (44%) had non-bipolar disorder; 89 (44%) had a history of previous substance misuse a history of previous substance misuse or dependence; and 179 (88%) were or dependence; and 179 (88%) were receiv receiving mood stabilisers (lithium or ing mood stabilisers (lithium or anticonvulsants) at baseline. anticonvulsants) at baseline.
Comparison of the 49 patients omitted Comparison of the 49 patients omitted with the 204 included, on the variables with the 204 included, on the variables later used in predictor analyses, showed later used in predictor analyses, showed some differences significant at the 5% level. some differences significant at the 5% level. Excluded patients had significantly higher Excluded patients had significantly higher baseline scores on the LIFE overall and baseline scores on the LIFE overall and depression scores, HRSD total score and depression scores, HRSD total score and 1. Separate ratings were made for depression and mania. Reproduced scale is slightly abridged, with rating scale cue 1. Separate ratings were made for depression and mania. Reproduced scale is slightly abridged, with rating scale cue scores for depression and mania combined. HRSD and MAS scores were specified as rough guidelines only. scores for depression and mania combined. HRSD and MAS scores were specified as rough guidelines only. 2. For analysis these levels were grouped to four: 1 2. For analysis these levels were grouped to four: 1¼no symptoms; 2 no symptoms; 2¼minor symptoms; 3,4 minor symptoms; 3,4¼sub-syndromal sympsub-syndromal symptoms; 5,6 toms; 5,6¼major disorder. major disorder.
MAS mania score, and shorter time since MAS mania score, and shorter time since resolution of last episode; and fewer of resolution of last episode; and fewer of them were receiving mood stablisers. them were receiving mood stablisers.
Symptom levels over 18 months Symptom levels over 18 months Table 2 shows the mean percentages of Table 2 shows the mean percentages of total months at the four grouped symptom total months at the four grouped symptom levels over the 18 months, separately levels over the 18 months, separately for participants in episode at baseline for participants in episode at baseline (depression, hypomania, mixed) and not (depression, hypomania, mixed) and not in episode. Individuals in episode tended in episode. Individuals in episode tended to spend more time at all symptomatic to spend more time at all symptomatic levels, and less time asymptomatic, than levels, and less time asymptomatic, than those not in baseline episode. For people those not in baseline episode. For people in episode initially, on the overall rating in episode initially, on the overall rating 28% of months were asymptomatic, 22% 28% of months were asymptomatic, 22% at minor symptom level, 33% at substantial at minor symptom level, 33% at substantial sub-syndromal level and 17% at major sub-syndromal level and 17% at major symptom level. Regarding people not initisymptom level. Regarding people not initially in episode, 55% of months were ally in episode, 55% of months were asymptomatic, 19% at substantial subasymptomatic, 19% at substantial subsyndromal level and 6% had major syndromal level and 6% had major symptoms. Consistently, in both groups, symptoms. Consistently, in both groups, about three times as much time was spent about three times as much time was spent with depressive symptoms as with manic with depressive symptoms as with manic symptoms. When the two episode groups symptoms. When the two episode groups were combined (not shown in the table), a were combined (not shown in the table), a mean of 47% of months were asymptomean of 47% of months were asymptomatic, 20% at minor symptom level, 23% matic, 20% at minor symptom level, 23% at sub-syndromal level and 10% at major at sub-syndromal level and 10% at major symptom level. symptom level.
Because patients excluded from analysis Because patients excluded from analysis ( (n n¼49) had characteristics suggesting a 49) had characteristics suggesting a worse prognosis, a further analysis was worse prognosis, a further analysis was undertaken, including them where possible. undertaken, including them where possible. This is shown in the data supplement to the This is shown in the data supplement to the online version of this paper, with scores for online version of this paper, with scores for the reported sample of 204 patients for the reported sample of 204 patients for comparison. For the overall severity rating, comparison. For the overall severity rating, inclusion of the omitted individuals would inclusion of the omitted individuals would have rendered about 4% fewer months have rendered about 4% fewer months asymptomatic, largely because of more asymptomatic, largely because of more months at major level, at least in the earlier, months at major level, at least in the earlier, less biased months. less biased months.
There was no unipolar comparison There was no unipolar comparison group in the present study, but a comgroup in the present study, but a comparison was available from a 10-year parison was available from a 10-year follow-up study (Kennedy follow-up study (Kennedy et al et al, 2004 (Kennedy et al et al, ), by , 2004 , by using only patients with at least one using only patients with at least one previous episode in that study. These previous episode in that study. These people spent a mean of 52% of follow-up people spent a mean of 52% of follow-up months asymptomatic, 20% at LIFE submonths asymptomatic, 20% at LIFE subsyndromal symptom levels, 15% with syndromal symptom levels, 15% with minor symptoms and 13% at major deminor symptoms and 13% at major depressive disorder level. These findings are pressive disorder level. These findings are very similar to overall severity for those very similar to overall severity for those not in episode in the present study, appronot in episode in the present study, appropriate for comparison since unipolar index priate for comparison since unipolar index major episodes had been up to 10 years major episodes had been up to 10 years earlier. This suggests that when mania and earlier. This suggests that when mania and depression are combined, symptom levels depression are combined, symptom levels are similar to unipolar disorder. are similar to unipolar disorder. Figure 1 plots the four symptom levels over Figure 1 plots the four symptom levels over time on the overall LIFE severity score, time on the overall LIFE severity score, separately for participants initially not in separately for participants initially not in episode and in episode. Levels remained episode and in episode. Levels remained approximately constant in those individuals approximately constant in those individuals not in episode at baseline. Those in baseline not in episode at baseline. Those in baseline episode showed a gradual improvement, episode showed a gradual improvement, with a greater proportion of time spent at with a greater proportion of time spent at lower symptom levels; however, even after lower symptom levels; however, even after 18 months they tended to spend less asymp-18 months they tended to spend less asymptomatic time than those not in baseline tomatic time than those not in baseline episode. As shown in the figures, only a episode. As shown in the figures, only a minority of the patients rated as in minority of the patients rated as in episode at baseline scored at the major episode at baseline scored at the major symptom level during the first month. This symptom level during the first month. This was because the others had improved since was because the others had improved since the episode, but not for sufficient time the episode, but not for sufficient time (8 weeks) to meet the DSM-IV criteria for (8 weeks) to meet the DSM-IV criteria for being out of episode. being out of episode. Table 3 shows the extent of changes in Table 3 shows the extent of changes in the grouped symptom levels during the the grouped symptom levels during the 18-month follow-up period. Over the 18 18-month follow-up period. Over the 18 months there were means of 5.4 changes months there were means of 5.4 changes in depression level, 3.0 changes in mania in depression level, 3.0 changes in mania and 6.0 changes in overall severity level. and 6.0 changes in overall severity level. Only 6% of participants remained at a Only 6% of participants remained at a constant level of overall severity throughconstant level of overall severity throughout the follow-up. Since these changes were out the follow-up. Since these changes were in levels averaged over 4 weeks, this reflects in levels averaged over 4 weeks, this reflects a considerable tendency to change levels. a considerable tendency to change levels. When examined separately, participants When examined separately, participants not in episode at baseline had a mean of not in episode at baseline had a mean of 5.7 changes and participants in episode 5.7 changes and participants in episode had a mean of 6.6 changes. had a mean of 6.6 changes.
Changes over time Changes over time
Variability in symptom level Variability in symptom level
Again, a partial unipolar comparison is Again, a partial unipolar comparison is provided by data from Kennedy provided by data from Kennedy et al et al (2004) . In that study monthly changes were (2004) . In that study monthly changes were less frequent, at a mean of two annually. less frequent, at a mean of two annually. Although in that retrospective study some Although in that retrospective study some changes might have been missed, and sympchanges might have been missed, and symptoms may tend to stabilise over the longer toms may tend to stabilise over the longer term, these findings suggest greater variaterm, these findings suggest greater variability in bipolar disorder. bility in bipolar disorder.
Judd Judd et al et al (2002) reported changes in (2002) reported changes in level weekly, so these were also examined. level weekly, so these were also examined. Over the entire sample there was a mean Over the entire sample there was a mean of 9.4 week-by-week changes in depression of 9.4 week-by-week changes in depression level and 5.4 in mania. For participants in level and 5.4 in mania. For participants in episode at baseline, the mean changes were episode at baseline, the mean changes were depression 11.3 and mania 7.2; for those depression 11.3 and mania 7.2; for those not in episode, the mean changes were not in episode, the mean changes were depression 8.6 and mania 4.6. depression 8.6 and mania 4.6.
Changes in polarity on the averaged Changes in polarity on the averaged monthly ratings during the study were monthly ratings during the study were infrequent. Only three patients showed infrequent. Only three patients showed changes from a major level of one pole to changes from a major level of one pole to a major level of the other. A larger number, a major level of the other. A larger number, 20 patients, showed changes from sub-20 patients, showed changes from subsyndromal levels in one direction to the syndromal levels in one direction to the other (12 individuals changing once, 7 other (12 individuals changing once, 7 twice and 1 three times). However, when twice and 1 three times). However, when weekly changes were examined, in order weekly changes were examined, in order to compare with Judd to compare with Judd et al et al (2002) 34 (2002) 34 (17%) participants showed changes from (17%) participants showed changes from a major level at one pole to a major level a major level at one pole to a major level at the other, allowing up to 8 weeks at the other, allowing up to 8 weeks between changes, and 15 of these people between changes, and 15 of these people showed more than one change. Such showed more than one change. Such 12 0 12 0 fluctuations therefore, although not infrefluctuations therefore, although not infrequent, tended to be brief. quent, tended to be brief.
Predictors of time spent Predictors of time spent at different symptom levels at different symptom levels
In order to examine whether predictors for In order to examine whether predictors for subsyndromal and major symptoms were subsyndromal and major symptoms were the same or different, two separate sets the same or different, two separate sets of analyses were undertaken to predict of analyses were undertaken to predict length of occurrence, respectively, of sublength of occurrence, respectively, of subsyndromal symptoms (overall LIFE levels syndromal symptoms (overall LIFE levels 3, 4) and of symptoms at major level 3, 4) and of symptoms at major level (overall LIFE levels 5, 6). Logistic re-(overall LIFE levels 5, 6). Logistic regression was used, since outcome distribugression was used, since outcome distributions were skewed. For each analysis the tions were skewed. For each analysis the outcome measure was dichotomised to outcome measure was dichotomised to short and long at the median length: for short and long at the median length: for sub-syndromal symptoms, 21% of followsub-syndromal symptoms, 21% of followup months ( up months (n n above above¼93, below 93, below¼111): for 111): for major symptoms, any ( major symptoms, any (n n¼103) 103) v v. none . none ( (n n¼101). A reduced set of 15 predictor 101). A reduced set of 15 predictor variables was derived from initial and backvariables was derived from initial and background variables, to focus on those likely to ground variables, to focus on those likely to be of relevance from the earlier literature be of relevance from the earlier literature but eliminating variables with substantial but eliminating variables with substantial overlap, low frequency or unreliability. overlap, low frequency or unreliability.
Significant predictors were very similar Significant predictors were very similar in the two analyses. More time at both in the two analyses. More time at both symptom levels was predicted significantly symptom levels was predicted significantly by more previous episodes, shorter time by more previous episodes, shorter time since resolution of the last episode, and since resolution of the last episode, and higher baseline HRSD and LIFE scores. higher baseline HRSD and LIFE scores. Significantly more time at one level and a Significantly more time at one level and a trend ( trend (P P5 50.10) for the other was predicted 0.10) for the other was predicted by higher social class, last episode depressive by higher social class, last episode depressive rather than manic, higher baseline MAS rather than manic, higher baseline MAS and history of substance misuse. Family hisand history of substance misuse. Family history of affective disorder in a first-degree tory of affective disorder in a first-degree relative predicted shorter time with major relative predicted shorter time with major symptoms ( symptoms (P P5 50.05), possibly owing to 0.05), possibly owing to chance. Only one variable, being in episode chance. Only one variable, being in episode at baseline, predicted in opposite directions at baseline, predicted in opposite directions for the two outcomes, predicting longer for the two outcomes, predicting longer time with major symptoms and shorter time time with major symptoms and shorter time with sub-syndromal symptoms, possibly with sub-syndromal symptoms, possibly because of the time spent with major disorbecause of the time spent with major disorder shortly after baseline. There was no der shortly after baseline. There was no significant prediction by gender, current significant prediction by gender, current age, age at first episode, lifetime comorbid age, age at first episode, lifetime comorbid diagnosis or being on a mood stabiliser at diagnosis or being on a mood stabiliser at baseline. baseline.
DISCUSSION DISCUSSION
This longitudinal study is the first of its This longitudinal study is the first of its kind reported in UK patients with bipolar kind reported in UK patients with bipolar disorder. It has found that sub-syndromal disorder. It has found that sub-syndromal symptoms constitute a considerable clinical symptoms constitute a considerable clinical element over time, present for twice as long element over time, present for twice as long as major symptoms. Patients not in episode as major symptoms. Patients not in episode at baseline did better than those in episode, at baseline did better than those in episode, but spent only half the time completely free but spent only half the time completely free of symptoms. Changes of symptom level of symptoms. Changes of symptom level were frequent. Predictors of substantial were frequent. Predictors of substantial sub-syndromal symptoms were similar to sub-syndromal symptoms were similar to those of major symptoms, predominantly those of major symptoms, predominantly related to greater severity and previous related to greater severity and previous history. history.
The study methods had some advanThe study methods had some advantages. Symptoms were evaluated more tages. Symptoms were evaluated more frequently than in most similar studies, by frequently than in most similar studies, by trained interviewers using established trained interviewers using established rating scales to anchor the LIFE ratings. rating scales to anchor the LIFE ratings. Although they all had had an illness episode Although they all had had an illness episode in the past year, more than half of the parin the past year, more than half of the participants were not in episode at baseline. ticipants were not in episode at baseline. Most follow-up studies start in an episode, Most follow-up studies start in an episode, weighting outcomes towards adverse, weighting outcomes towards adverse, except in the very long term. Furthermore, except in the very long term. Furthermore, the sample was large and from diverse the sample was large and from diverse centres. centres.
There were also some limitations. There were also some limitations. Participants were selected for a cognitive Participants were selected for a cognitive therapy trial, albeit one aiming at wide therapy trial, albeit one aiming at wide inclusion. Criteria excluded patients wtih inclusion. Criteria excluded patients wtih first episodes, mania until improved and refirst episodes, mania until improved and recent rapid cycling, and there were some cent rapid cycling, and there were some trial refusals. Some of these weight towards trial refusals. Some of these weight towards more recurrence and some against it. Biases more recurrence and some against it. Biases in trial recruitment tend to produce betterin trial recruitment tend to produce betterprognosis patients, but in this study outprognosis patients, but in this study outcome was relatively poor. Overall, the come was relatively poor. Overall, the participants were probably representative participants were probably representative of patients with bipolar disorder in the care of patients with bipolar disorder in the care 121 121 
Comparisons with other studies Comparisons with other studies
Although minor forms of the bipolar specAlthough minor forms of the bipolar spectrum without major episodes, such as trum without major episodes, such as cyclothymia and bipolar II disorder, are cyclothymia and bipolar II disorder, are well recognised (Akiskal, 1983 well recognised (Akiskal, 1983a a) , there ), there has been considerably less attention paid has been considerably less attention paid to subthreshold symptoms between major to subthreshold symptoms between major episodes. episodes.
The major most directly comparable The major most directly comparable US study (Judd US study (Judd et al et al, 2002) reported on , 2002) reported on longitudinal state over 13 years in 146 longitudinal state over 13 years in 146 patients with bipolar I disorder, using patients with bipolar I disorder, using weekly LIFE scores but based on retrospecweekly LIFE scores but based on retrospective ratings, initially 6-monthly and later tive ratings, initially 6-monthly and later annually. Patients were asymptomatic annually. Patients were asymptomatic about 50% of the time, spent about 15% about 50% of the time, spent about 15% of the time at sub-syndromal level, another of the time at sub-syndromal level, another 20% with minor symptoms, and only 12% 20% with minor symptoms, and only 12% of weeks with major disorder. These findof weeks with major disorder. These findings are comparable with those for our paings are comparable with those for our patients not in episode at baseline. In both tients not in episode at baseline. In both studies depressive symptoms predominated studies depressive symptoms predominated over manic and hypomanic symptoms, over manic and hypomanic symptoms, and changes in symptom levels over time and changes in symptom levels over time were frequent. Judd were frequent. Judd et al et al (2002) found six (2002) found six changes in weekly ratings per year. changes in weekly ratings per year.
Morriss (2002) has reviewed the limited Morriss (2002) has reviewed the limited additional literature on inter-episode subadditional literature on inter-episode subclinical symptoms in bipolar disorder, using clinical symptoms in bipolar disorder, using studies with less systematic longitudinal studies with less systematic longitudinal assessment. Inter-episode symptoms, often assessment. Inter-episode symptoms, often fluctuating and sometimes prodromal to fluctuating and sometimes prodromal to relapse, have been reported in a number relapse, have been reported in a number of studies (Molnar of studies (Molnar et al et al, 1987; Dion , 1987; Dion et al et al, , 1988; Keller 1988; Keller et al et al, 1992; Gitlin , 1992; Gitlin et al et al, , 1995; Keitner 1995; Keitner et al et al, 1996) . Recently Joffe , 1996). Recently Joffe et al et al (2004) found that 50% of the time (2004) found that 50% of the time over a year or more, patients with bipolar over a year or more, patients with bipolar I and II disorder were euthymic, 41% were I and II disorder were euthymic, 41% were depressed and only 6% manic. Studies have depressed and only 6% manic. Studies have also pointed to considerable associated soalso pointed to considerable associated social disability. We will report on impaired cial disability. We will report on impaired social adjustment in the present study social adjustment in the present study separately. separately.
Few studies have examined predictors Few studies have examined predictors of subthreshold symptoms separately. of subthreshold symptoms separately. Nolen Nolen et al et al (2004), combining major and (2004) , combining major and lesser symptoms, found severity of depreslesser symptoms, found severity of depression and mania predicted by more previous sion and mania predicted by more previous depressive and manic episodes respectively; depressive and manic episodes respectively; and mania only was predicted by comorbid and mania only was predicted by comorbid substance misuse, which is somewhat simisubstance misuse, which is somewhat similar to our study. Our main finding was that lar to our study. Our main finding was that predictors of sub-syndromal symptoms and predictors of sub-syndromal symptoms and of major disorder were essentially the same, of major disorder were essentially the same, in spite of the theoretical possibility that in spite of the theoretical possibility that longer periods of one might leave less time longer periods of one might leave less time for the other. This suggests that major for the other. This suggests that major and sub-syndromal symptoms are part of and sub-syndromal symptoms are part of the same continuous phenomenon, which the same continuous phenomenon, which is also strongly supported by the frequent is also strongly supported by the frequent changes in levels over the range. changes in levels over the range.
There is more extensive literature on There is more extensive literature on residual and sub-syndromal symptoms in residual and sub-syndromal symptoms in unipolar affective disorder and on lowerunipolar affective disorder and on lowergrade subtypes, including dysthymic disgrade subtypes, including dysthymic disorder (Akiskal, 1983 order (Akiskal, 1983b b) , recurrent brief ), recurrent brief depression (Angst depression (Angst et al et al, 1990) and sub-, 1990 ) and subsyndromal depression (Judd syndromal depression (Judd et al et al, 1994) . , 1994). It has become clear that similar subIt has become clear that similar subthreshold symptoms occur following and threshold symptoms occur following and between major depressive episodes (Paykel between major depressive episodes (Paykel et al et al, 1995; Judd , 1995; Judd et al et al, 1998) , with consid-, 1998), with considerable continuity between major and minor erable continuity between major and minor forms. Our comparison with the Kennedy forms. Our comparison with the Kennedy et al et al (2004) follow-up study suggests that (2004) follow-up study suggests that symptom levels tend to be similar over time symptom levels tend to be similar over time in bipolar and unipolar disorder, but that in bipolar and unipolar disorder, but that variability is greater in the former. variability is greater in the former.
Therapeutic implications Therapeutic implications
Our findings underline the need for careful Our findings underline the need for careful monitoring of the mental state of people monitoring of the mental state of people with bipolar disorder, and for continuation with bipolar disorder, and for continuation and maintenance treatment, particularly for and maintenance treatment, particularly for those who have had an episode in the past those who have had an episode in the past year. year.
There have been very few treatment There have been very few treatment studies to target sub-syndromal symptoms. studies to target sub-syndromal symptoms. Keller Keller et al et al (1992) reported a controlled (1992) reported a controlled trial in which patients with bipolar disorder trial in which patients with bipolar disorder received lithium doses at higher plasma received lithium doses at higher plasma levels of 0.8-1.0 mmol/l or lower levels of levels of 0.8-1.0 mmol/l or lower levels of 0.4-0.6 mmol/l. Both inter-episode sub-0.4-0.6 mmol/l. Both inter-episode subsyndromal symptoms and major relapses syndromal symptoms and major relapses were reduced. This study merits were reduced. This study merits replication and greater attention in treatreplication and greater attention in treatment recommendations. Some other studies ment recommendations. Some other studies have shown benefit on symptom ratings or have shown benefit on symptom ratings or affective morbidity, but without separating affective morbidity, but without separating morbidity due to major relapse. These inmorbidity due to major relapse. These include trials of lithium, valproate (Bowden clude trials of lithium, valproate (Bowden et al et al, 2000) and lamotrigine (Bowden , 2000) and lamotrigine (Bowden et et al al, 2003) .
, 2003).
There have been limited attempts to There have been limited attempts to examine effects of cognitive-behavioural examine effects of cognitive-behavioural therapy (CBT) and other psychological therapy (CBT) and other psychological therapies on symptoms rather than relapse. therapies on symptoms rather than relapse. Scott Scott et al et al (2001) , in a small pilot con-(2001), in a small pilot controlled trial, found significant benefit on trolled trial, found significant benefit on symptom self-ratings in patients receiving symptom self-ratings in patients receiving CBT. However, in the large controlled trial CBT. However, in the large controlled trial from which the present sample was derived, from which the present sample was derived, CBT did not produce any benefit on LIFE CBT did not produce any benefit on LIFE scores. Lam scores. Lam et al et al (2003) found limited (2003) found limited effect of CBT on symptom ratings and effect of CBT on symptom ratings and larger effects on relapse prevention. larger effects on relapse prevention. Miklowitz Miklowitz et al et al (2003) also reported some (2003) also reported some benefit on mood symptom ratings from benefit on mood symptom ratings from family-focused psychoeducation. Again, family-focused psychoeducation. Again, these analyses have not distinguished these analyses have not distinguished symptoms during relapse from intersymptoms during relapse from interepisode symptoms. episode symptoms.
The findings of high prevalence of interThe findings of high prevalence of interepisode sub-syndromal symptoms in bipolar episode sub-syndromal symptoms in bipolar disorder, confirmed in the present study, disorder, confirmed in the present study, mandate greater vigilance in clinical mandate greater vigilance in clinical practice in detecting and treating these to practice in detecting and treating these to obtain a symptom-free state, and point to obtain a symptom-free state, and point to the needs for these issues to be incorporated the needs for these issues to be incorporated into treatment guidelines, and for further into treatment guidelines, and for further therapeutic trials aimed at ameliorating therapeutic trials aimed at ameliorating these symptoms. these symptoms.
